How Dismantling DEI Efforts Could Make Clinical Trials Less Representative | JAMA | JAMA Network

How Dismantling DEI Efforts Could Make Clinical Trials Less Representative | JAMA | JAMA Network: 

Excerpt: ″At least 3 major drug companies, all headquartered in Europe—Roche and Novartis in Switzerland and GSK in the UK—have moved to follow Trump’s DEI executive orders by eliminating it from their hiring and training practices.″

Source: jamanetwork.com